The company has successfully defended its trademarked ForsLean ingredient, which was contested by Creative Compounds LLC’s marketing of an ingredient called “Forsthin.”
Sabinsa Corp. (East Windsor, NJ) has successfully defended its trademarked ForsLean ingredient, which was contested by Creative Compounds LLC’s (Scott City, MO) marketing of an ingredient called “Forsthin.” Both ingredients are Coleus forskohlii extracts.
A district court ruling originally ruled that the two ingredients could not be confused with each other, but in July 2010, the U.S. Court of Appeals ruled against Creative Compounds over copyright infringement.
On January 10, the U.S. Supreme Court denied Creative Compounds’ petition for judicial review, indicating that there was potential for confusion surrounding the two ingredients.
The full language of the Supreme Court’s decision in favor of Sabinsa ForsLean is currently available.
The Nutritional Outlook Podcast Episode 36: Best of the Industry Service Provider, Radicle Science
December 26th 2024Nutritional Outlook's managing editor, Sebastian Krawiec, interviews Radicle Science co-founders, Pelin Thorogood and Jeff Chen, MD. Radicle Science has been selected as this year's Best of the Industry, Service Provider.
Hard to compete with horseradish
January 10th 2025Fun fact! Horseradish can be difficult to eradicate once it’s established. This is because the smallest piece of root can grow a new plant. Additionally, the plant spreads by underground shoots that out-compete most other plants which means horseradish can become invasive if not maintained.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.